Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission (Q34598577)

From Wikidata

Jump to navigation Jump to search

scholarly article

Language	Label	Description	Also known as
English	Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission	scholarly article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

HIV transmission

0 references

0 references

prevention of HIV/AIDS

0 references

1 reference

based on heuristic

inferred from title

author name string

S Palmer

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

V Boltz

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

N Martinson

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

F Maldarelli

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

G Gray

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J McIntyre

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J Mellors

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

L Morris

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J Coffin

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

25 April 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

7094-7099

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Prevention of mother-to-child transmission of HIV--successes, controversies and critical questions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Treatment of HIV infection in pregnant women: antiretroviral management options.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Pregnancy and HIV infection: A european consensus on management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Nevirapine resistance after single dose prophylaxis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

HIV-1/AIDS and maternal and child health in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

International perspectives on antiretroviral resistance. Nonnucleoside reverse transcriptase inhibitor resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Development of nonnucleoside HIV reverse transcriptase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

7 July 2018

HIV-infected pregnant women and vertical transmission in Europe since 1986

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group P

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Comparison of a Chemically Mediated and an Immunologically Mediated Demyelinating Lesion Model

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Structured treatment interruption in patients with multidrug-resistant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602033103

21 January 2018

Detection of minority populations of HIV-1 expressing the K103N resistance mutation in patients failing nevirapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

26 October 2018

HIV-infected pregnant women and vertical transmission in Europe since 1986. European collaborative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1459023

26 October 2018

Identifiers

10.1073/PNAS.0602033103

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2006PNAS..103.7094P

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34598577&oldid=1647489836"